Bernd R. Seizinger - May 18, 2022 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ Scott M. Coiante, attorney-in-fact
Stock symbol
APRE
Transactions as of
May 18, 2022
Transactions value $
$35,500
Form type
4
Date filed
5/19/2022, 04:31 PM
Previous filing
Jul 1, 2021
Next filing
Aug 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Purchase $35.5K +50K +18.62% $0.71* 319K May 18, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.